Beijing Scitop Bio Tech Co Ltd (300858) — Capital Reinvestment Ratio
Latest as of September 2025:
1.59x
Beijing Scitop Bio Tech Co Ltd (300858) has a Capital Reinvestment Ratio of 1.59x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥44.72 Million) in capital expenditures (CN¥70.94 Million). See Beijing Scitop Bio Tech Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.59x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥44.72 Million
CNY
Capital Expenditures
CN¥70.94 Million
CNY
Data as of
Sep 2025
Most recent filing
Beijing Scitop Bio Tech Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks Beijing Scitop Bio Tech Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Beijing Scitop Bio Tech Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. For live market cap and broader valuation context, see 300858 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.40x | CN¥123.44 Million | CN¥296.12 Million | ▲ +61.2% |
| 2024 | 1.49x | CN¥142.11 Million | CN¥211.50 Million | ▼ -10.6% |
| 2023 | 1.66x | CN¥107.27 Million | CN¥178.47 Million | ▲ +193.4% |
| 2022 | 0.57x | CN¥148.46 Million | CN¥84.18 Million | ▼ -7.5% |
| 2021 | 0.61x | CN¥110.27 Million | CN¥67.57 Million | ▲ +92.0% |
| 2020 | 0.32x | CN¥66.67 Million | CN¥21.28 Million | ▼ -32.2% |
| 2019 | 0.47x | CN¥98.27 Million | CN¥46.25 Million | ▼ -56.1% |
| 2018 | 1.07x | CN¥89.55 Million | CN¥95.99 Million | ▲ +90.6% |
| 2017 | 0.56x | CN¥84.00 Million | CN¥47.25 Million | ▼ -12.6% |
| 2016 | 0.64x | CN¥32.73 Million | CN¥21.06 Million | ▼ -69.5% |
| 2015 | 2.11x | CN¥2.69 Million | CN¥5.66 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow